Saturday, December 12, 2015

BREAST CANCER RESEARCH RIGHT NOW! #40: After Tamoxifen and Anastrazole…


http://breastcancernow.org/sites/default/files/public/styles/featured_image_large__870x489_/public/drugs.jpg?itok=pr3R1jeEFrom the first moment my wife discovered she had breast cancer, there was a deafening silence from the men I know. Even ones whose wives, mothers or girlfriends had breast cancer seemed to have received a gag order from some Central Cancer Command and did little more than mumble about the experience. Not one to shut up for any known reason, I started this blog…

Every month, I’ll be highlighting breast cancer research that is going on RIGHT NOW! Harvested from different websites, journals and podcasts, I’ll translate them into understandable English and share them with you. Today: http://www.sciencedaily.com/releases/2015/12/151211132333.htm

My wife is coming up on FIVE YEARS post-mastectomy; five months later will be five years post chemotherapy.


In it, the research team discovered that “although both drugs were safe and effective, and had no detrimental effect on overall quality of life, there were some differences in the type and severity of symptoms the women experienced with each treatment, and these especially differed by age.”

The differences they say, are in the details. So what does this mean?

In women under 60, “tamoxifen [patients] complained of more severe hot flashes” as for  those taking anastrozole, they found that they had “greater severity of vaginal dryness and muscle and joint pains; hot flashes, weight problems, vaginal symptoms and gynecological symptoms”

Neither drug had any significant  negative effect on women over 60; and overall, “The research also indicated that symptoms such as depression and fatigue were no different in comparison between the two drugs and did not increase in patients during the five years of treatment.” Of course, this implies that depression and fatigue are going to be common factors in post-treatment women, no matter their age.

Drug treatment for women with breast cancer is going to be brutal. However, this study simply shows that doctors need to choose wisely when prescribing the drug to patients of different ages. Better still, PATIENTS in-the-know can make sure that their providers are making the best choices for them.

No comments:

Post a Comment